Islet Holdings Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
1998
1999
2000
2001
Sales/Revenue
1,160.80
1,074.00
726.70
636.60
Gross Income
869.90
778.20
459.50
425.80
Non Operating Income/Expense
0.00
8.20
44.20
13.50
Pretax Income
534.40
1,048.60
1,010.40
3,423.70
Income Tax
0.00
0.00
0.00
0.00
Equity in Affiliates
0.00
0.00
0.00
0.00
Consolidated Net Income
534.40
1,048.60
1,010.40
3,423.70
Net Income After Extraordinaries
0.00
0.00
0.00
0.00
EPS (Basic)
0.11
0.17
0.12
0.22
Basic Shares Outstanding
4,766.30
6,307.30
8,711.60
15,779.30
EPS (Diluted)
0.11
0.17
0.12
0.22
Diluted Shares Outstanding
4,766.30
6,307.30
8,711.60
15,779.30
Other Operating Expense
0.00
0.00
0.00
0.00
Non-Operating Interest Income
0.00
0.00
-
-
Minority Interest Expense
0.00
0.00
0.00
0.00
Equity in Affiliates (Pretax)
0.00
0.00
0.00
0.00
Other After Tax Income (Expense)
0.00
0.00
0.00
0.00
Preferred Dividends
0.00
0.00
0.00
0.00

About Islet Holdings

View Profile
Address
7609 Ralston Road
Arvada Colorado 80002
United States
Employees -
Website http://www.isletholding.com
Updated 07/08/2019
Islet Holdings Inc. engages in the research, development, and commercialization of patented technologies in the field of transplantation therapy for people with conditions of insulin-dependent diabetes. The company was founded on December 10, 1981 and is headquartered in Arvada, CO. .